Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

AZITHROMYCIN

AZITHROMYCIN

Standard Dose
EQ 200MG BASE/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview AZITHROMYCIN is listed in Drugs@FDA under application 217036 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient AZITHROMYCIN Form and strength FOR SUSPENSION;ORAL - EQ 200MG BASE/5ML Sponsor ZHEJIANG POLY PHARM Submission history Latest submission status date: 2023-07-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview AZITHROMYCIN is listed in Drugs@FDA under application 217036 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient AZITHROMYCIN Form and strength FOR SUSPENSION;ORAL - EQ 200MG BASE/5ML Sponsor ZHEJIANG POLY PHARM Submission history Latest submission status date: 2023-07-27 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.